A Randomized Trial of Itraconazole in Allergic Bronchopulmonary Aspergillosis
Top Cited Papers
- 16 March 2000
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 342 (11) , 756-762
- https://doi.org/10.1056/nejm200003163421102
Abstract
Allergic bronchopulmonary aspergillosis is a hypersensitivity disorder that can progress from an acute phase to chronic disease. The main treatment is systemic corticosteroids, but data from uncontrolled studies suggest that itraconazole, an orally administered antifungal agent, may be an effective adjunctive therapy.Keywords
This publication has 40 references indexed in Scilit:
- Allergic Bronchopulmonary Aspergillosis in Patients With Cystic FibrosisChest, 1994
- Corticosteroid treatment and prognosis in pulmonary eosinophilia.Thorax, 1989
- What happens to patients with pulmonary aspergilloma? Analysis of 23 cases.Thorax, 1983
- Allergic Bronchopulmonary Aspergillosis: Staging as an Aid to ManagementAnnals of Internal Medicine, 1982
- Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmaticsJournal of Allergy and Clinical Immunology, 1981
- The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosisThe American Journal of Medicine, 1978
- Clinical and Immunologic Criteria for the Diagnosis of Allergic Bronchopulmonary AspergillosisAnnals of Internal Medicine, 1977
- Asthmatic pulmonary eosinophilia: A review of 65 casesRespiratory Medicine, 1977
- The radiological appearances in allergic broncho-pulmonary aspergillosisClinical Radiology, 1970
- Broncho-pulmonary Aspergillosis : A Review and a Report of Eight New CasesThorax, 1952